AU2023352012A1 - Sterilized heterocyclidene-acetamide-derivative-containing suspension - Google Patents

Sterilized heterocyclidene-acetamide-derivative-containing suspension Download PDF

Info

Publication number
AU2023352012A1
AU2023352012A1 AU2023352012A AU2023352012A AU2023352012A1 AU 2023352012 A1 AU2023352012 A1 AU 2023352012A1 AU 2023352012 A AU2023352012 A AU 2023352012A AU 2023352012 A AU2023352012 A AU 2023352012A AU 2023352012 A1 AU2023352012 A1 AU 2023352012A1
Authority
AU
Australia
Prior art keywords
suspension liquid
aqueous suspension
liquid formulation
acetamide
trifluoromethylchroman
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2023352012A
Other languages
English (en)
Inventor
Yuki Yamashita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Mochida Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd, Mochida Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Publication of AU2023352012A1 publication Critical patent/AU2023352012A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2023352012A 2022-09-29 2023-09-28 Sterilized heterocyclidene-acetamide-derivative-containing suspension Pending AU2023352012A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2022-156060 2022-09-29
JP2022156060 2022-09-29
PCT/JP2023/035547 WO2024071348A1 (ja) 2022-09-29 2023-09-28 滅菌処理したヘテロシクリデンアセトアミド誘導体含有懸濁液

Publications (1)

Publication Number Publication Date
AU2023352012A1 true AU2023352012A1 (en) 2025-04-03

Family

ID=90478164

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2023352012A Pending AU2023352012A1 (en) 2022-09-29 2023-09-28 Sterilized heterocyclidene-acetamide-derivative-containing suspension

Country Status (7)

Country Link
EP (1) EP4595959A1 (cg-RX-API-DMAC7.html)
JP (2) JP7589393B2 (cg-RX-API-DMAC7.html)
KR (1) KR20250065723A (cg-RX-API-DMAC7.html)
CN (1) CN119997937A (cg-RX-API-DMAC7.html)
AU (1) AU2023352012A1 (cg-RX-API-DMAC7.html)
MX (1) MX2025003326A (cg-RX-API-DMAC7.html)
WO (1) WO2024071348A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025206172A1 (ja) * 2024-03-28 2025-10-02 千寿製薬株式会社 電子線滅菌処理したヘテロシクリデンアセトアミド誘導体含有組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4754566B2 (ja) 2005-07-22 2011-08-24 持田製薬株式会社 新規なヘテロシクリデンアセトアミド誘導体
JP6230743B1 (ja) 2017-05-31 2017-11-15 持田製薬株式会社 ヘテロシクリデンアセトアミド誘導体の結晶
WO2021039023A1 (ja) 2019-08-23 2021-03-04 持田製薬株式会社 ヘテロシクリデンアセトアミド誘導体の製造方法
CN112409191A (zh) 2019-08-23 2021-02-26 持田制药株式会社 光学活性的氨基醇的制备方法
BR112022005992A2 (pt) 2019-10-04 2022-06-21 Mochida Pharm Co Ltd Fármaco contendo derivado de heterociclideno acetamida
JP7663009B2 (ja) 2021-03-31 2025-04-16 ニデックパワートレインシステムズ株式会社 回転電機、およびポンプ

Also Published As

Publication number Publication date
JPWO2024071348A1 (cg-RX-API-DMAC7.html) 2024-04-04
CN119997937A (zh) 2025-05-13
MX2025003326A (es) 2025-05-02
EP4595959A1 (en) 2025-08-06
JP2025024083A (ja) 2025-02-19
JP7589393B2 (ja) 2024-11-25
KR20250065723A (ko) 2025-05-13
WO2024071348A1 (ja) 2024-04-04

Similar Documents

Publication Publication Date Title
US20170196802A1 (en) Long Acting Injectable Formulations
TWI544934B (zh) 含有氟喹諾酮抗生素藥物之經改良藥學組成物
MX2011005217A (es) Formulaciones que comprenden ceftiofur y cetoprofeno o ceftiofur y alcohol bencilico.
RU2705376C2 (ru) Композиции пролекарства арипипразола
US12527740B2 (en) Suspension containing heterocyclidene acetamide derivative
IL293541A (en) Ophthalmic preparations
CA2798575C (en) Pharmaceutical composition of ibuprofen for injection
JP7589393B2 (ja) 滅菌処理したヘテロシクリデンアセトアミド誘導体含有懸濁液
JP4188084B2 (ja) トラマドールとジクロフェナクの塩の懸濁液を含有する非経口投与可能な剤形
CA3268119A1 (en) Sterilized heterocyclidene-acetamide-derivative-containing suspension
US10463674B2 (en) Process for manufacturing sterile ophthalmic pharmaceutical suspensions
US20260091018A1 (en) Combination preparation containing heterocyclidene acetamide derivative
KR20220144359A (ko) 점안제로부터의 보존제 제거
WO2025206172A1 (ja) 電子線滅菌処理したヘテロシクリデンアセトアミド誘導体含有組成物
WO2024256956A1 (en) Stable formulations of bilastine for nasal and ophthalmic use
WO2023148763A1 (en) Injectable pharmaceutical compositions of azole antifungal agents
WO2022195382A1 (en) A stable ophthalmic nanosupension of brinzolamide